Marcie A. Goldstein

Davis Polk advised the representatives of the several underwriters in connection with the initial public offering by Rocket Companies, Inc. of 100,000,000 shares of Rocket Companies’ Class…

Davis Polk advised the sales agent on the SEC-registered at-the-market offering by Turning Point Therapeutics, Inc. of its common stock for up to an aggregate amount of $250 million…

Davis Polk advised the representatives of the several underwriters in connection with the $703.5 million initial public offering of 33,500,000 shares of common stock of Rackspace Technology…

Davis Polk advised the representative of the several underwriters in connection with the initial public offering of 82,800,00 units of CC Neuberger Principal Holdings II, including 10,800…

Davis Polk advised the underwriters in connection with the SEC-registered offering by BioXcel Therapeutics, Inc. of 4,000,000 shares of its common stock. The common stock is listed on the…

Davis Polk advised the underwriters in connection with an initial public offering of 11,000,000 shares of common stock of Nurix Therapeutics, Inc. at $19 per share, for total gross proceeds…

Davis Polk advised the representatives of the underwriters in connection with the $511.5 million SEC-registered offering of 5,500,000 American Depositary Shares of BioNTech SE. In addition,…

Davis Polk advised the sole book runner in connection with the initial public offering of 30,000,000 units of East Resources Acquisition Company for aggregate proceeds of $300 million. Each…

Davis Polk advised the representatives of the several underwriters in connection with the $538.2 million initial public offering of 20,700,000 shares of common stock of Jamf Holding Corp.,…

Davis Polk advised the underwriters in connection with an initial public offering of 9,315,000 shares of common stock of Berkeley Lights, Inc. at $22.00 per share (which includes the…